Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-162-02
Published January 6, 2021 · Recall initiated: December 17, 2020
Summary
FDA records drug Class II recall D-0184-2021, published January 6, 2021 and initiated December 17, 2020. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 490,633 vials; Lot: Batch # 6121125, Exp 02/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter - found in reserve sample vials at the firm.
What to do
Voluntary: Firm initiated · Letter
Get an email if KETOROLAC TROMETHAMINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- KETOROLAC TROMETHAMINE
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- USA Nationwide and Puerto Rico
- UPC
- 0363323162115
- Lot
- Batch # 6121125, Exp 02/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAKetorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular UseOctober 29, 2025
- FDAKetorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc.,October 8, 2025
- FDAKetorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., Toronto,July 2, 2025
- FDAKetorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only,August 24, 2022
- FDAEsomeprazole Magnesium for Delayed-Release Oral Suspension 40mg, packaged in unit dose packets, Rx only,January 6, 2021
- FDAHappy Ducts Compress, 3 oz. plastic jar, www.wishgardenherbs.com, Boulder, CO. 80301. UPC 6 56490 20223 5January 6, 2021
Questions about this recall
Was Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-162-02 recalled?
Yes. FDA published recall D-0184-2021 on January 6, 2021. Reported hazard: Presence of Particulate Matter - found in reserve sample vials at the firm.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: KETOROLAC TROMETHAMINE. UPC: 0363323162115.